Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Mise à jour : Il y a 4 ans
Référence : NCT00657657

Femme et Homme

  • | Pays :
  • Thailand
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

In this study, subjects who received primary neonatal vaccination with hepatitis B vaccine at 0, 1, 2, 12 months, 20 years ago in the 103860/272 primary study will be evaluated for immunological memory to hepatitis B vaccine via assessment of the response to a vaccine challenge dose.


Critère d'inclusion

  • Hepatitis B

Liens